Advertisement
Two of three planned adaptive phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19 have launched

NIH Launches Clinical Trials of Antithrombotics for COVID-19

0
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
The overall prevalence of severe acute respiratory syndrome coronavirus 2 antibodies is 24.4 percent in a cohort of asymptomatic health care workers

24.4 Percent of U.K. Health Care Workers Positive for SARS-CoV-2

0
Seroprevalence varies for health care workers in different departments; rate lower for ICU staff
For the first time in six months

Canada Reports No New COVID-19 Deaths for First Time in Six Months

0
As of Saturday, there had been 137,676 COVID-19 cases and 9,214 deaths from the illness in Canada
Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.

AstraZeneca COVID-19 Vaccine Trial Restarts

0
Trial was halted after a suspected adverse reaction in a patient
A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled

Effectiveness of Inhaled COVID-19 Vaccines to Be Studied

0
Trial will test responses of 30 adults when they inhale vaccine droplets in their mouths
Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients' recovery time

Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients

0
Adding anti-inflammatory drug to remdesivir seems to shorten time to hospital discharge
The parents of a 13-year-old boy in Florida who died from brain-eating amoeba want to warn others about the risk of the waterborne infection.

Florida Teen Dies From Brain-Eating Amoeba

0
Naegleria fowleri can get into the brain when contaminated water enters the nose
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 7 to 11 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Pneumothorax is being reported as a complication of COVID-19

Pneumothorax Reported as Complication of COVID-19

0
Higher incidence seen among men; survival at 28 days lower for those 70 years of age or older
Young adults hospitalized with COVID-19 have substantial rates of adverse outcomes

Considerable Adverse Outcomes Reported for Young Adults With COVID-19

0
Young adults hospitalized with COVID-19 have substantial rate of adverse outcomes; 2.7 percent died